Changes in the diversity and composition of gut microbiota in pigeon squabs infected with Trichomonas gallinae

Pigeons, as the only altricial birds in poultry, are the primary Trichomonas gallinae (T. gallinae) host. To study the effects of T. gallinae infection on gut microbiota, we compared the microbiota diversity and composition in gastrointestinal (GI) tracts of pigeons at the age of 14 and 21 day with different degrees of T. gallinae infection. Thirty-six nestling pigeons were divided into three groups: the healthy group, low-grade and high-grade trichomonosis group. Then, the crop, small intestine and rectum contents were obtained for sequencing of the 16S rRNA gene V3–V4 hypervariable region. The results showed that the microbiota diversity was higher in crop than in small intestine and rectum, and the abundance of Lactobacillus genus was dominant in small intestine and rectum of healthy pigeons at 21 days. T. gallinae infection decreased the microbiota richness in crop at 14 days. The abundance of the Firmicutes phylum and Lactobacillus genus in small intestine of birds at 21 days were decreased by infection, however the abundances of Proteobacteria phylum and Enterococcus, Atopobium, Roseburia, Aeriscardovia and Peptostreptococcus genus increased. The above results indicated that crop had the highest microbiota diversity among GI tract of pigeons, and the gut microbiota diversity and composition of pigeon squabs were altered by T. gallinae infection.

Effects of Mannan Oligosaccharides and/or Bifidobacterium on Growth and Immunity in Domestic Pigeon (Columba livia domestica)

The goal of this study was to evaluate the influences of mannan oligosaccharides (MOSs) and/or Bifidobacterium on the growth and immunity of pigeons over a 56-day period. One hundred paired adult pigeons were randomly divided into four groups of five paired pigeons. Paired pigeons with two young squabs were housed in a man-made aviary. Parent pigeons in the control group received a basal diet (C), while the other three groups were fed with the basal diet supplemented with 20 g of MOSs/kg of feed (M), 10 g Bifidobacterium (1×1010 CFU/g)/kg of feed (B), or a combination of M and B (MB). We found higher body weights (BW) in pigeons of the B group than in the C, M, and MB groups. None of the treatments exerted significant effects involving spleen and thymus indices, whereas M birds tended to improve the bursa of Fabricius index. Pigeons fed with the M-supplemented diet exhibited improved serum immunoglobulin M (IgM) concentrations compared with those fed with C and the B- and MB-supplemented diets. In addition, M treatment increased immunoglobulin A (IgA) levels compared with MB treatment. MB treatment improved serum immunoglobulin G (IgG) concentrations compared to that by the C treatment. The concentration of secretory immunoglobulin A (sIgA) was significantly reduced in the duodenum and increased in the ileum in pigeons fed with the MB-supplemented diet. This study indicated that dietary supplementation with Bifidobacterium increased the growth performance. Dietary supplementation with MOSs or in combination with Bifidobacterium was able to improve immune function in pigeons but exerted no apparent effect on weight gain. Accordingly, in terms of economic benefits, the findings suggested that supplementation with Bifidobacterium alone may improve production performance, and that supplementation with MOSs alone may improve immune function in pigeons.

Prebiotics: A Potential Treatment Strategy for the Chemotherapy-damaged Gut?

Mucositis, characterized by ulcerative lesions along the alimentary tract, is a common consequence of many chemotherapy regimens. Chemotherapy negatively disrupts the intestinal microbiota, resulting in increased numbers of potentially pathogenic bacteria, such as Clostridia and Enterobacteriaceae, and decreased numbers of "beneficial" bacteria, such as Lactobacilli and Bifidobacteria. Agents capable of restoring homeostasis in the bowel microbiota could, therefore, be applicable to mucositis. Prebiotics are indigestible compounds, commonly oligosaccharides, that seek to reverse chemotherapy-induced intestinal dysbiosis through selective colonization of the intestinal microbiota by probiotic bacteria. In addition, evidence is emerging that certain prebiotics contribute to nutrient digestibility and absorption, modulate intestinal barrier function through effects on mucin expression, and also modify mucosal immune responses, possibly via inflammasome-mediated processes. This review examines the known mechanisms of prebiotic action, and explores their potential for reducing the severity of chemotherapy-induced mucositis in the intestine.

Package of NDV-pseudotyped HIV-Luc virus and its application in the neutralization assay for NDV infection

Newcastle disease virus (NDV) is a member of the Paramyxovirinae subfamily and can infect most species of birds. It has been a great threat for the poultry industry all around the world. In this report, we successfully produced infectious pseudotyped pNL4-3-Luc-R⁻E⁻ (HIV-Luc) viruses with the HN and F envelope proteins of NDV. Further investigation revealed the cytoplasmic domains of HN and F, especially HN, plays a significant role in the infection efficiency of these pseudotyped HIV-Luc viruses. Replacement of, or direct fusion to the cytoplasmic domain of the HN protein by that of vesicular stomatitis virus G (VSV-G) could greatly enhance or destroy the infective potential of HN and F-pseudotyped (NDV-pseudotyped) HIV-Luc virus. We further established a novel neutralization assay to evaluate neutralizing antibodies against NDV with the NDV-pseudotyped HIV-Luc viruses. Comparative neutralization data indicate that the results determined by using the NDV-pseudotyped HIV-Luc viruses are as reliable as those by the conventional virus-neutralization assay (VN test) with native NDV. Moreover, the results show that the novel neutralization assay is more sensitive than the VN test.